P1131 SIMILAR ADJUSTED SVR12 RATES FOR HIV CO-INFECTED AND HCV MONO-INFECTED PATIENTS AND NO DOSE OR POPULATION (TREATMENT-NAIVE/RELAPSER) EFFECT: POOLED ANALYSIS OF FALDAPREVIR PHASE III TRIALS

Autor: Dieterich, D., Ferenci, P., Jacobson, I.M., Negro, F., Puoti, M., Rockstroh, J.K., Manns, M.P., Arastéh, K., Oliveira, C., Dufour, J.-F., Zehnter, E., Leen, C., Bhagani, S., Stern, J.O., Quinson, A.-M., Scherer, J., Manero, M., Jensen, D.M.
Zdroj: In Journal of Hepatology April 2014 60(1) Supplement:S458-S458
Databáze: ScienceDirect
Externí odkaz: